Castlecomer, Ireland

Brendan Kelly

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
7 patents (USPTO):

Title: Brendan Kelly: Innovator in Menin-MLL Interaction Inhibitors

Introduction

Brendan Kelly is a prominent inventor based in Castlecomer, Ireland. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of inhibitors targeting the menin-MLL interaction. With a total of 7 patents to his name, Kelly's work is paving the way for new therapeutic approaches to treat various diseases.

Latest Patents

Among his latest patents, Kelly has disclosed innovative compounds that inhibit the binding of menin and MLL or MLL fusion proteins. One of his notable patents focuses on the development of heterocyclic compounds that serve as specific inhibitors of the menin-MLL interaction. These compounds are designed to be used in pharmaceutical compositions aimed at treating autoimmune diseases, heteroimmune diseases, and cancers such as lymphoma and leukemia. Another significant patent involves substituted pyridines that act as irreversible inhibitors of the menin-MLL interaction, further expanding the potential therapeutic applications of his research.

Career Highlights

Brendan Kelly is currently associated with Biomea Fusion, Inc., where he continues to advance his research in the field of medicinal chemistry. His work has garnered attention for its potential to revolutionize treatment options for conditions that depend on menin-MLL interaction.

Collaborations

Kelly collaborates with esteemed colleagues, including Thomas Butler and Jim Palmer, who contribute to the innovative research environment at Biomea Fusion, Inc. Their combined expertise enhances the development of groundbreaking therapeutic solutions.

Conclusion

Brendan Kelly's contributions to the field of pharmaceutical sciences, particularly through his patents on menin-MLL interaction inhibitors, highlight his role as a leading inventor. His work promises to impact the treatment of various diseases significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…